Core Products and Services

BMC will develop and produce therapeutics based on viruses, cells and antibodies for clients in academia and the pharmaceutical industry.

Products include:

  • Oncolytic viruses
  • Viral vectors for gene and cell therapy
  • Vaccines
  • Mesenchymal stem cells
  • Somatic Cells
  • Genetically-enhanced stem / progenitor cells

Services include:

  • Innovation services that will expand the knowledge base on virus and cell manufacturing.
  • Upstream and downstream process development.
  • New assay development and assay qualification/validation services.
  • cGMP manufacturing of clinical-scale virus products, cell banks, and individualized cell therapies.
  • Development and execution of validated SOPs for clinical sample processing in accordance with the ICH Q2 guidelines.
  • Stability and storage programs.
  • Client cell line storage.
  • GMP manufacturing of Master Cell Bank.
  • Creation of viral master seed bank.
  • Manufacturing process development, optimization and validation.
  • Purification process development and optimization.
  • Pilot virus batch manufacturing.
  • GMP virus clinical lot manufacturing (bulk drug substance, drug product).
  • Manufacturing and quality documentation (and regulatory support as needed).
  • Co-development of virus-based therapeutics.